QMCF Technology: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''QMCF Technology''' is a proprietary technology developed by [[Proteros Biostructures]] for use in [[drug discovery]]. It is designed to facilitate the production of [[protein]]s and [[protein complex]]es for [[structural biology]] and [[biophysical]] studies. | '''QMCF Technology''' is a proprietary technology developed by [[Proteros Biostructures]] for use in [[drug discovery]]. It is designed to facilitate the production of [[protein]]s and [[protein complex]]es for [[structural biology]] and [[biophysical]] studies. | ||
Latest revision as of 15:54, 8 March 2025
QMCF Technology is a proprietary technology developed by Proteros Biostructures for use in drug discovery. It is designed to facilitate the production of proteins and protein complexes for structural biology and biophysical studies.
Overview[edit]
QMCF Technology stands for "Quasi-Emulsion Concentration and Microfluidic Flow" technology. It is a method that combines cell culture techniques with microfluidics to enhance the expression and purification of proteins. This technology is particularly useful in the field of structural biology, where high-quality protein samples are essential for X-ray crystallography and NMR spectroscopy.
Applications[edit]
QMCF Technology is primarily used in the pharmaceutical industry for the discovery and development of new therapeutics. By enabling the efficient production of proteins, it supports the identification of drug targets and the optimization of lead compounds.
Advantages[edit]
- High Yield: QMCF Technology allows for the production of large quantities of proteins, which is crucial for biophysical analysis.
- Scalability: The technology can be scaled up to meet the demands of industrial applications.
- Versatility: It is applicable to a wide range of protein types, including membrane proteins and protein complexes.
